157 related articles for article (PubMed ID: 25020053)
1. Comparison of follitropin alfa and urinary gonadotropins in IVF cycles.
Sahmay S; Usta TA; Zebitay G; Senturk LM; Oral E; Ocal P; Idil M; Irez T
Minerva Ginecol; 2014 Aug; 66(4):341-6. PubMed ID: 25020053
[TBL] [Abstract][Full Text] [Related]
2. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
Bjercke S; Tanbo T; Abyholm T; Omland A; Opøien HK; Fedorcsak P
Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1053-60. PubMed ID: 20602599
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis.
Palomba S; Caserta D; Levi-Setti PE; Busnelli A
J Ovarian Res; 2024 Mar; 17(1):60. PubMed ID: 38486276
[TBL] [Abstract][Full Text] [Related]
6. [The effect of corifollitropin alfa on in vitro fertilization-ICSI patients with previous failure with an FSH/HMG protocol: Preliminary report in Mexico].
Barroso-Villa JG; Colín-Valenzuela A; Valdespín-Fierro C; Ávila-Lombardo R; Estrada-Gutiérrez G
Ginecol Obstet Mex; 2016 Jan; 84(1):7-13. PubMed ID: 27290841
[TBL] [Abstract][Full Text] [Related]
7. Could the addition of hp-hMG and GnRH antagonists modulate the response in IVF-ICSI cycles?
Requena A; Landeras JL; Martínez-Navarro L; Calatayud C; Sánchez F; Maldonado V; Muñoz M; Fernández M; González A; López S; López R; Pacheco A; Calderón G; Martínez V
Hum Fertil (Camb); 2010 Mar; 13(1):41-9. PubMed ID: 20384441
[TBL] [Abstract][Full Text] [Related]
8. Individualized ovarian stimulation for in vitro fertilization: a multicenter, open label, exploratory study with a mixed protocol of follitropin delta and highly purified human menopausal gonadotropin.
Bissonnette F; Minano Masip J; Kadoch IJ; Librach C; Sampalis J; Yuzpe A
Fertil Steril; 2021 Apr; 115(4):991-1000. PubMed ID: 33267959
[TBL] [Abstract][Full Text] [Related]
9. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
Dahan MH; Agdi M; Shehata F; Son W; Tan SL
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
[TBL] [Abstract][Full Text] [Related]
10. Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF/ICSI procedures (DELTA Study).
Porcu-Buisson G; Maignien C; Swierkowski-Blanchard N; Rongières C; Ranisavljevic N; Oger P; Decanter C; Hocké C; Bry-Gauillard H; Grynberg M; Barrière P; Bernot M; Guivarc'h-Levêque A
Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():21-26. PubMed ID: 38100937
[TBL] [Abstract][Full Text] [Related]
11. Impact of recombinant FSH dose adjustments on ovarian response in the second treatment cycle with IVF or ICSI in "standard" patients treated with 150 IU/day during the first cycle.
Popovic-Todorovic B; Loft A; Ziebe S; Andersen AN
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):842-9. PubMed ID: 15315596
[TBL] [Abstract][Full Text] [Related]
12. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
[TBL] [Abstract][Full Text] [Related]
13. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
Ye H; Huang G; Pei L; Zeng P; Luo X
Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of ovarian stimulation with follitropin delta in a mixed regimen with HP-hMG: a real-world retrospective analysise.
Lim LJ; Kit AMF; Wong PS
Med J Malaysia; 2024 May; 79(3):275-280. PubMed ID: 38817059
[TBL] [Abstract][Full Text] [Related]
15. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
16. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome.
Strehler E; Abt M; El-Danasouri I; De Santo M; Sterzik K
Fertil Steril; 2001 Feb; 75(2):332-6. PubMed ID: 11172835
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of results of two flexible ovarian hiperestimulation protocols with two different initial doses (150 vs ≥ 225)].
Barros-Delgadillo JC; Ruiz-Balderrama CI; Ríos-Barba M
Ginecol Obstet Mex; 2015 Jan; 83(1):1-15. PubMed ID: 26016311
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian stimulation with gonadotropins: comparison between recombinant FSH plus menotropins versus recombinant FSH + LH].
Santibáñez Morales A; Colín Licea EO; Durán Boullosa E; Sánchez Serrano P; Pashkova O
Ginecol Obstet Mex; 2014 May; 82(5):307-13. PubMed ID: 24937946
[TBL] [Abstract][Full Text] [Related]
19. An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation.
Vlaisavljević V; Meden-Vrtovec H; Lewandowski P; Radwan M; Langerova A; Vicena M; Války J; Herman M; Usoniene A; Treijs G
Curr Med Res Opin; 2010 Apr; 26(4):819-25. PubMed ID: 20121657
[TBL] [Abstract][Full Text] [Related]
20. IVF protocol efficacy in women with expected suboptimal response depending on ovary stimulation mode.
Ob'edkova KV; Kogan IY; Muller VC; Tapilskaya NI; Krikhely IO; Dzhemlikhanova LK; Abdulkadirova ZK; Mekina ID; Lesik EA; Komarova EA; Ishchuk MA; Gzgzian AM
Gynecol Endocrinol; 2021; 37(sup1):44-48. PubMed ID: 34937512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
